CN Patent

CN106822005A — 奥贝胆酸组合物及其制备方法

Assigned to Hainan Simcere Pharmaceutical Co ltd · Expires 2017-06-13 · 9y expired

What this patent protects

本发明涉及一种拥有良好溶出效果的奥贝胆酸组合物及其制备方法，该组合物包括奥贝胆酸、共微载体及口服固体制剂药学上可接受辅料。制备方法将奥贝胆酸与共微载体粉碎，再与口服固体制剂药学上可接受辅料混合均匀；或者将奥贝胆酸粉碎，再与共微载体、口服固体制剂药学上可接受辅料混合均匀，所得组合物的溶出度有大幅提高。

USPTO Abstract

本发明涉及一种拥有良好溶出效果的奥贝胆酸组合物及其制备方法，该组合物包括奥贝胆酸、共微载体及口服固体制剂药学上可接受辅料。制备方法将奥贝胆酸与共微载体粉碎，再与口服固体制剂药学上可接受辅料混合均匀；或者将奥贝胆酸粉碎，再与共微载体、口服固体制剂药学上可接受辅料混合均匀，所得组合物的溶出度有大幅提高。

Drugs covered by this patent

Patent Metadata

Patent number
CN106822005A
Jurisdiction
CN
Classification
—
Expires
2017-06-13
Drug substance claim
No
Drug product claim
No
Assignee
Hainan Simcere Pharmaceutical Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.